会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • NOVEL 1,1-BIS(HETEROAZOLYL)ALKANE DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE AGENTS
    • 新型1,1-BIS(HETEROAZOLYL)ALKANE衍生物及其作为神经保护剂
    • WO1995033747A1
    • 1995-12-14
    • PCT/SE1995000604
    • 1995-05-29
    • ASTRA AKTIEBOLAGBOAR, Bernard, RobinGRAY, Duncan, AlastairO'SHEA, Dennis, Mark
    • ASTRA AKTIEBOLAG
    • C07D417/06
    • C07D263/32A61K31/427C07D277/24C07D277/28
    • The present invention relates to novel heterocyclic compounds having general formula (1), wherein: X1 and X2 are independently O, S or Se; Y1 and Y2 are independently C or N with the proviso that at least one of Y1 and Y2 is N; Y3 and Y4 are independently C or N with the proviso that at least one of Y3 and Y4 is N; R1 and R2 each represent one or more groups independently selected from H, lower alkyl, lower alkoxy-lower alkyl, hydroxy-lower alkyl, lower acyloxy-lower alkyl or CF3; and A is (a) or (b) geometrical and optical isomers and racemates thereof where such isomers exist, as well as pharmaceutically acceptable acid addition salts thereof and solvates thereof; having therapeutic activity, processes and intermediates for their preparation, pharmaceutical formulations containing said compounds and the medicinal use of said compounds.
    • 本发明涉及具有通式(1)的新型杂环化合物,其中:X 1和X 2独立地为O,S或Se; Y1和Y2独立地为C或N,条件是Y1和Y2中的至少一个为N; Y 3和Y 4独立地为C或N,条件是Y 3和Y 4中的至少一个为N; R 1和R 2各自表示一个或多个独立地选自H,低级烷基,低级烷氧基 - 低级烷基,羟基 - 低级烷基,低级酰氧基 - 低级烷基或CF 3的基团; 和A是(a)或(b)其中存在这些异构体的几何和光学异构体及其外消旋体,以及其药学上可接受的酸加成盐和溶剂合物; 具有治疗活性,其制备方法和中间体,含有所述化合物的药物制剂和所述化合物的医药用途。
    • 7. 发明申请
    • 1-SUBSTITUTED ISATIN AND OXINDOLE DERIVATIVES AS INHIBITORS OF ACETYLCHOLINESTERASE
    • 作为乙酰胆碱酯酶抑制剂的1-取代的ISATIN和氧化衍生物
    • WO1994029272A1
    • 1994-12-22
    • PCT/SE1994000448
    • 1994-05-13
    • ASTRA AKTIEBOLAGBOAR, Bernard, RobinO'SHEA, Dennis, MarkTOMLINSON, Ian, David
    • ASTRA AKTIEBOLAG
    • C07D209/34
    • C07D491/10C07D209/34C07D209/38
    • The present invention relates to novel compounds having general formula (1) wherein n is 3, 4, 5, 6 or 7; X represents one or more substituents independently selected from hydrogen, lower alkyl, aryl, lower alkoxy, halogen, trifluoromethyl, nitro, -NHCOR where R is lower alkyl or aryl, -NR1R2 where R1 and R2 are independently hydrogen or lower alkyl or together form a ring, or cycloalkyl, cycloalkenyl or bicycloalkyl either optionally further substituted by lower alkyl; Y is (a) or (b) where R3 and R4 are independently hydrogen, lower alkyl, lower alkoxy or together form a cyclic acetal; Z is lower alkyl; and W represents one or more substituents independently selected from hydrogen, lower alkyl, lower alkoxy or halogen; stereo and optical isomers and racemates thereof where such isomers exist, as well as pharmaceutically acceptable acid addition salts thereof and solvates thereof having therapeutic activity, intermediates for their preparation, processes for their preparation, pharmaceutical formulations containing said compounds and medicinal use of said compounds.
    • 本发明涉及具有通式(1)的新化合物,其中n为3,4,5,6或7; X表示一个或多个独立地选自氢,低级烷基,芳基,低级烷氧基,卤素,三氟甲基,硝基,-NHCOR的取代基,其中R是低级烷基或芳基,-NR1R2,其中R1和R2独立地是氢或低级烷基或一起形成 环或环烷基,任选进一步被低级烷基取代的环烯基或二环烷基; Y是(a)或(b),其中R 3和R 4独立地是氢,低级烷基,低级烷氧基或一起形成环缩醛; Z是低级烷基; W表示一个或多个独立地选自氢,低级烷基,低级烷氧基或卤素的取代基; 其中存在这些异构体的立体和旋光异构体及其外消旋体,以及其药学上可接受的酸加成盐和具有治疗活性的溶剂合物,其制备中间体,其制备方法,含有所述化合物的药物制剂和所述化合物的药用。